Clinical Trials Logo

Candidiasis, Oral clinical trials

View clinical trials related to Candidiasis, Oral.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06120816 Active, not recruiting - Candidiasis, Oral Clinical Trials

Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis

Start date: January 20, 2024
Phase: Phase 1
Study type: Interventional

Phase 1 Single Centre, open-labeled Clinical Trial to Evaluate the Safety and Tolerability of Topical Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis. Participants that meet all inclusion and exclusion criteria will be enrolled to receive open label NORM 3 doses/day for three weeks.

NCT ID: NCT05358743 Active, not recruiting - Clinical trials for Oral Candida Albicans Infection

Effect of Probiotics on Oral Candida Among Denture Wearers

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Forty-eight denture wearers with detectable levels of candida colonization without clinical symptoms will be randomly allocated into two groups: probiotics and placebo. All patients will take a daily dose of chewable tablets (probiotics or placebo according to the assigned group) for 8 weeks. Samples of mouth rinse will be collected from patients at baseline, 4 weeks from the beginning of the intervention, 8 weeks (the end of intervention), and after another 4 weeks for post-intervention follow up. Samples will be tested for both candida count and candida species identification